Keyword: Pharmaceuticals

News

Novartis Loses Landmark India Cancer Drug Patent Case

02.04.2013 - India's top court dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive...

News

Pfizer Fails to End Lawsuit Over Bextra, Celebrex Safety

29.03.2013 - Pfizer has failed to persuade a federal judge to dismiss a shareholder lawsuit accusing the company of fraudulently misrepresenting the safety of its Celebrex and Bextra pain...

News

U.S. Struggles with Pharmaceutical Goals in Asia Trade Talks

29.03.2013 - The United States is striving to find an appropriate balance in Asia-Pacific free trade talks between providing strong patent and data protections for U.S. drug manufacturers and...

News

Big Pharma in Nervous Wait for India Verdict on Glivec Patent

27.03.2013 - Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their...

News

Recipharm Site Approved for Supply of Manufactured Products to Japan

27.03.2013 - Recipharm's solid dose facility located in Fontaine, France, has been approved for supply of manufactured products to the Japan's pharmaceuticals market following a recent...

News

AstraZeneca Settles Crestor Patent Dispute

25.03.2013 - AstraZeneca has seen off a remaining threat to its top-selling cholesterol drug Crestor by settling a U.S. legal case with Watson Laboratories, a unit of Actavis, and Egis. The...

News

Roche Stays a Step Ahead of Copycat Drugmakers

25.03.2013 - Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...

News

Top U.S. Court to Decide on Deals to Delay Cheaper Drugs

23.03.2013 - The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...